Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

922 related articles for article (PubMed ID: 26872375)

  • 1. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis.
    Wu T; Qu L; He G; Tian L; Li L; Zhou H; Jin Q; Ren J; Wang Y; Wang J; Kan X; Liu M; Shen J; Guo M; Sun Y
    Oncotarget; 2016 Mar; 7(10):11553-66. PubMed ID: 26872375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
    Jili S; Eryong L; Lijuan L; Chao Z
    Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA PVT1 promotes laryngeal squamous cell carcinoma development by acting as a molecular sponge to regulate miR-519d-3p.
    Zheng X; Zhao K; Liu T; Liu L; Zhou C; Xu M
    J Cell Biochem; 2019 Mar; 120(3):3911-3921. PubMed ID: 30304557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-144-3p, a tumor suppressive microRNA targeting ETS-1 in laryngeal squamous cell carcinoma.
    Zhang SY; Lu ZM; Lin YF; Chen LS; Luo XN; Song XH; Chen SH; Wu YL
    Oncotarget; 2016 Mar; 7(10):11637-50. PubMed ID: 26826553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
    Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
    Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of laryngeal squamous cell cancer progression by the lncRNA RP11-159K7.2/miR-206/DNMT3A axis.
    Wang X; Yu B; Jin Q; Zhang J; Yan B; Yang L; Li Y; Li Q; Wang P; Sun C; Liu M; Tian L; Sun Y
    J Cell Mol Med; 2020 Jun; 24(12):6781-6795. PubMed ID: 32363688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β-induced long non-coding RNA MIR155HG promotes the progression and EMT of laryngeal squamous cell carcinoma by regulating the miR-155-5p/SOX10 axis.
    Cui W; Meng W; Zhao L; Cao H; Chi W; Wang B
    Int J Oncol; 2019 Jun; 54(6):2005-2018. PubMed ID: 31081043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-148a-3p Suppresses the Proliferation and Invasion of Esophageal Cancer by Targeting DNMT1.
    Wang Y; Hu Y; Guo J; Wang L
    Genet Test Mol Biomarkers; 2019 Feb; 23(2):98-104. PubMed ID: 30735457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA MNX1-AS1 drives aggressive laryngeal squamous cell carcinoma progression and serves as a ceRNA to target FoxM1 by sponging microRNA-370.
    Cui X; Yu H; Yu T; Xiao D; Wang X
    Aging (Albany NY); 2021 Mar; 13(7):9900-9910. PubMed ID: 33882027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H19/miR-107/HMGB1 axis sensitizes laryngeal squamous cell carcinoma to cisplatin by suppressing autophagy in vitro and in vivo.
    Chen L; Xu Z; Zhao J; Zhai X; Li J; Zhang Y; Zong L; Peng H; Qi J; Kong X; Fang Z; Liu M
    Cell Biol Int; 2021 Mar; 45(3):674-685. PubMed ID: 33314408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
    Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B
    Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p.
    Zheng Y; Duan L; Yang Y; Luo D; Yan B
    Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC01605 promotes the proliferation of laryngeal squamous cell carcinoma through targeting miR-493-3p.
    Wang XY; Wang L; Xu PC; Huang FJ; Jian X; Wei ZC; Chen YQ
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10379-10386. PubMed ID: 31841192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
    Shi J; Tan S; Song L; Song L; Wang Y
    Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA RGMB-AS1 promotes laryngeal squamous cell carcinoma cells progression via sponging miR-22/NLRP3 axis.
    Xu Z; Xi K
    Biomed Pharmacother; 2019 Oct; 118():109222. PubMed ID: 31351424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paired Box 5-Induced LINC00467 Upregulation Promotes the Progression of Laryngeal Squamous Cell Cancer by Triggering the MicroRNA-4735-3p/TNF Alpha-Induced Protein 3 Pathway.
    Li Y; Wu Y; Dai L; Wu H; Chen C; Ni J; Jin E; Zhou X
    Mol Biotechnol; 2023 Apr; 65(4):655-667. PubMed ID: 36214976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA XIST promotes the progression of laryngeal squamous cell carcinoma via sponging miR-125b-5p to modulate TRIB2.
    Liu C; Lu Z; Liu H; Zhuang S; Guo P
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32149330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA AGAP2-AS1 promotes cell proliferation and invasion through regulating miR-193a-3p/LOXL4 axis in laryngeal squamous cell carcinoma.
    Ren P; Niu X; Zhao R; Liu J; Ren W; Dai H; Chen J; Yan J; Li B; Shao Y; Bai Y; Han P
    Cell Cycle; 2022 Apr; 21(7):697-707. PubMed ID: 35113007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA XIST increases the aggressiveness of laryngeal squamous cell carcinoma by regulating miR-124-3p/EZH2.
    Xiao D; Cui X; Wang X
    Exp Cell Res; 2019 Aug; 381(2):172-178. PubMed ID: 31071316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA OIP5-AS1 serves as an oncogene in laryngeal squamous cell carcinoma by regulating miR-204-5p/ZEB1 axis.
    Wang H; Qian J; Xia X; Ye B
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2177-2184. PubMed ID: 32009213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.